Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic

BACKGROUND: Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Donaldson, Mark, Norbeck, Amber Olivia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798170/
https://www.ncbi.nlm.nih.gov/pubmed/24155855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798170/
https://www.ncbi.nlm.nih.gov/pubmed/24155855

Ejemplares similares